Back to December 2009: Updates from the 2009 San Antonio Breast Cancer Symposium
Adjuvant Zometa beneficial in post-menopausal women?
- Question from MaryA: Is there any new data indicating that Zometa shows a survival benefit when given to postmenopausal women in the adjuvant setting?
- Answer —Kathy Miller, M.D. : It's a short answer — no. We have at least three large studies comparing the addition of Zometa or not to the other standard treatments that women have received, that have finished enrolling patients, but we have not yet seen results. Those studies enrolled a much broader group of patients, so they included both pre-menopausal and post-menopausal women and those who received chemotherapy, but we are still awaiting the results of those studies.